Wordt geladen...

Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides

The enormous promise of siRNA technology for rational and targeted therapy can only be realized if the inherent problems in terms of pharmaceutical development are overcome. Besides liposomal and polymeric nanoparticles, fusion proteins hold great potential for cell-type specific delivery of siRNA....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Winkler, Johannes
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2011
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3272463/
https://ncbi.nlm.nih.gov/pubmed/22318893
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!